2016
International Pediatric MS Study Group Global Members Symposium report
Wassmer E, Chitnis T, Pohl D, Amato MP, Banwell B, Ghezzi A, Hintzen RQ, Krupp LB, Makhani N, Rostásy K, Tardieu M, Tenembaum S, Waldman A, Waubant E, Kornberg AJ. International Pediatric MS Study Group Global Members Symposium report. Neurology 2016, 87: s110-s116. PMID: 27572855, PMCID: PMC10688073, DOI: 10.1212/wnl.0000000000002880.Peer-Reviewed Original ResearchMeSH KeywordsChildCognition DisordersHumansInternational CooperationMultiple SclerosisPediatricsVitamin D DeficiencyConceptsPediatric multiple sclerosisMultiple sclerosisInternational Pediatric Multiple Sclerosis Study GroupMultiple Sclerosis Study GroupOptimal vitamin D intakeEarly-onset multiple sclerosisNewer MS agentsAcute disseminated encephalomyelitisVitamin D intakeVitamin D deficiencyChildhood multiple sclerosisLong-term outcomesDrug treatment optionsDiverse patient samplesDifferentiation of MSEffective cognitive rehabilitationD intakeDisseminated encephalomyelitisD deficiencyNeuroinflammatory disordersNeuromyelitis opticaMS riskTreatment optionsMS outcomesClinical trials
2006
Vitamin D as a Neuroactive Substance: Review
Kiraly SJ, Kiraly MA, Hawe RD, Makhani N. Vitamin D as a Neuroactive Substance: Review. The Scientific World JOURNAL 2006, 6: 125-139. PMID: 16493517, PMCID: PMC5917139, DOI: 10.1100/tsw.2006.25.Peer-Reviewed Original ResearchConceptsVitamin DCentral nervous systemNeuroactive substancesNervous systemImportant neuroactive substanceVitamin D insufficiencyCommon neuropsychiatric conditionsNerve growth factorD insufficiencyCochrane reviewCalcium metabolismBone metabolismHormonal effectsTarget organsClinical relevanceMore researchNeuroactive propertiesNeuropsychiatric conditionsGrowth factorNeuroactive compoundsCell differentiationPhysiological importanceMetabolismReviewSteroid derivatives